Spectral AI FY2024 EPS Forecast Increased by HC Wainwright

Spectral AI, Inc. (NASDAQ:MDAI) – Equities research analysts at HC Wainwright upped their FY2024 EPS estimates for shares of Spectral AI in a note issued to investors on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.46) per share for the year, up from their previous estimate of ($0.66). HC Wainwright has a “Buy” rating and a $3.50 price objective on the stock. The consensus estimate for Spectral AI’s current full-year earnings is ($0.57) per share. HC Wainwright also issued estimates for Spectral AI’s Q4 2024 earnings at ($0.09) EPS, Q2 2025 earnings at ($0.15) EPS, Q3 2025 earnings at ($0.15) EPS, Q4 2025 earnings at ($0.16) EPS, FY2025 earnings at ($0.64) EPS and FY2026 earnings at $0.33 EPS.

Other equities analysts also recently issued research reports about the company. Northland Capmk upgraded Spectral AI to a “strong-buy” rating in a report on Monday, August 12th. Northland Securities initiated coverage on shares of Spectral AI in a research report on Monday, August 12th. They set an “outperform” rating and a $6.00 price target for the company.

Spectral AI Stock Up 2.2 %

MDAI opened at $1.38 on Monday. Spectral AI has a 52 week low of $0.82 and a 52 week high of $3.72. The stock has a market cap of $25.54 million, a PE ratio of -2.12 and a beta of 0.48. The business has a 50 day moving average of $1.26 and a 200-day moving average of $1.53.

Spectral AI (NASDAQ:MDAI) last posted its quarterly earnings data on Monday, August 12th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). The business had revenue of $7.48 million during the quarter, compared to analyst estimates of $6.00 million.

Hedge Funds Weigh In On Spectral AI

Hedge funds have recently bought and sold shares of the company. Murchinson Ltd. bought a new stake in shares of Spectral AI during the first quarter valued at approximately $85,000. Virtu Financial LLC purchased a new position in shares of Spectral AI in the first quarter worth $38,000. Finally, Forum Financial Management LP bought a new position in shares of Spectral AI during the second quarter valued at $51,000. Institutional investors own 67.08% of the company’s stock.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.